Milestone Pharmaceuticals Inc.
MIST· Nasdaq
MISTMilestone Pharmaceuticals Inc.
Filed May 12, 2022 · 10-Q · 42 days after period end · 0001558370-22-008418
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Net Income | -$14.01M | -$12.51M | -$16.34M | -$10.45M |
| EPS Diluted | -$0.33 | -$0.30 | -$0.67 | -$17.32 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 12, 2022 · 42 d after period end
